FENC vs RMD · rev $17.9M vs P/E 29, rev $5.65B
Fennec Pharmaceuticals Inc (FENC) versus ResMed Inc (RMD) — a side-by-side from cached financials, not a winner call.
Fennec Pharmaceuticals Inc (FENC) is a biotechnology company listed on US.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Latest reported FENC revenue for 2026-06-30 was $17.9M. Net income was $2.0M. Revenue was up 18.3% from 2026-03-31 to 2026-06-30. FENC currently screens at market cap $302.2M.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
FENC currently screens at market cap $302.2M. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Not investment advice. Open the FENC and RMD stock pages for the full models.
Not investment advice.